PREVALENCE OF MORTALITY BY COVID-19 IN PREGNANT WOMEN WITH HEART DISEASE (2020 UP TO 2023)
Article Sidebar
Main Article Content
Abstract
COVID-19 is an infectious disease caused by the SARS-CoV-2 coronavirus, initially identified in China in late 2019. It spread rapidly and evolved into a pandemic and was declared a Public Health Emergency of International Concern. Its symptoms range from mild to severe, and can progress to Severe Acute Respiratory Syndrome and, in more severe cases, lead to death. The objective of this study is to describe the mortality profile in pregnant women living with heart disease diagnosed with COVID-19 in 2022. This is an exploratory epidemiological study with a quantitative approach and retrospective design. The data were obtained through the Influenza Epidemiological Surveillance Information System (SIVEP-Gripe), referring to the year 2022 and covering the entire national territory. A total of 6,326 pregnant women were notified, of which 46.4% had risk factors and of these 18.75% had heart disease. Considering the prevalence ratio, it can be stated that a woman living with cardiomyopathy has a 60.6 greater chance of dying. It is worth mentioning that the results analyzed cases of pregnant women who died and were diagnosed with cardiomyopathy. In 2022, deaths of pregnant women diagnosed with cardiomyopathy and COVID-19 peaked at the beginning of the year, followed by a downward trend. This behavior may be related to the evolution of public health policies, especially the increase in vaccination coverage.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c). Conjuncture Bulletin (BOCA)
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
ABREU, L. C. et al. “A time-series ecological study protocol to analyze trends of incidence, mortality, lethality of COVID-19 in Brazil”. Journal of Human Growth and Development, vol. 31, n. 3, 2021. BRASIL. “Covid-19: situação epidemiológica do Brasil até a SE 10 de 2023”. Gov.br [2023]. Disponível em: . Acesso em: 12/02/2025.
AVILA WS, CARVALHO RC. COVID-19: A New Challenge in Pregnancy and Heart Disease. Arq Bras Cardiol. 2020 Jul;115(1):1-4. English, Portuguese. doi: 10.36660/abc.20200511. Epub 2020 Aug 7. PMID: 32785494; PMCID: PMC8384333.
BRITO, S. A. et al. “Three years of COVID-19 pandemic: comparative analysis of incidence, lethality and mortality among the States of the south region of Brazil”. Journal of Human Growth and Development, vol. 33, n. 3, 2023.
CALABRÒ, G. E. et al. “The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence”. Vaccines, vol. 11, n. 5, 2023.
CALLAWAY, E. “COVID’s future: mini-waves rather than seasonal surges”. Nature, vol. 617, 2023.
DABOIN, B. E. G. et al. “Deciphering Multifactorial Correlations of COVID-19 Incidence and Mortality in the Brazilian Amazon Basin. Int J Environ Res Public Health”. Revista de Saúde Coletiva, vol. 19, n. 3, 2022.
FREITAS, C. M. et al. Covid-19 no Brasil: cenários epidemiológicos e vigilância em saúde. Rio de Janeiro: FIOCRUZ, 2021.
HAGAVATHULA, A. S. “The Impact of COVID-19 on Mortality in Italy: Retrospective Analysis of Epidemiological Trends”. JMIR Public Health and Surveillance, vol. 8, 2022.
IEEE Security and Privacy, vol. 6, 2023. WHO - World Health Organization. Coronavirus disease (COVID-19). Geneva: WHO, 2020. Available in: . Access in: 12/02/2025.
LI, Q. et al. “Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia”. New England Journal of Medicine, vol. 382, n. 13, 2020..
LUCENA FILHO, R. B. et al. “Blockchain e sua influência na qualidade das informações contábeis: uma análise bibliométrica. Boletim de Conjuntura (BOCA), vol. 21, n. 61, 2025.
MAIA, P. C. G. G. S. et al. “Space-temporal analysis of the incidence, mortality and case fatality of COVID-19 in the State of Rio Grande do Norte, in the period from 2020 to 2022, in the Northeast of Brazil”. Journal of Human Growth and Development, vol. 24, n. 1, 2024.
MARQUES-SANTOS C, AVILA WS, CARVALHO RCM, LUCENA AJG, FREIRE CMV, ALEXANDRE ERG, Et. al. Posicionamento sobre COVID-19 e Gravidez em Mulheres Cardiopatas – Departamento de Cardiologia da Mulher da Sociedade Brasileira de Cardiologia – 2020. Arq Bras Cardiol. 2020; 115(5):975-986.
MINISTÉRIO DA SAÚDE. Coronavírus Brasil. Brasília: Ministério da Saúde, 2020. Disponível em: . Acesso em: 23/02/2025.
MOOLLA, I.; HIILAMO, H. “Health system characteristics and COVID-19 performance in high income countries”. BMC Health Services Research, vol. 23, n. 1, 2023.
MOURA, E. C. et al. “Covid-19: evolução temporal e imunização nas três ondas epidemiológicas, Brasil, 2020–2022”. Revista de Saúde Pública, vol. 56, 2022.
MURALIDAR, S. et al. “The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2”. Biochimie, vol. 179, 2020.
OPAS - Organização Pan-Americana da Saúde. “Histórico da pandemia de COVID-19”. OPAS [2020]. Available in: . Accessed on: 12/01/2025.
PAPANDRÉA, P. J. “Blockchain e Contabilidade: Aplicação de um Novo Modelo de Registro de Dados com sua Imutabilidade”. Revista e-Locução, vol. 1, n. 24, 2023.
PIERCE-WILLIAMS, A. M. et al. “Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study”. American Journal of Obstetrics and Gynecology MFM, vol. 2, n. 3,2020. ROVETTA, A.; B
SHOOK, L. L. et al. “COVID-19 vaccination in pregnancy and lactation: current research and gaps in understanding. Frontiers in Cellular and Infection Microbiology, vol. 11, 2021.
SIQUEIRA, T. S. et al. “Spatial clusters, social determinants of health and risk of maternal mortality by COVID-19 in Brazil: a national population-based ecological study”. The Lancet Regional Health - Americas, vol. 3, 2021.
SOEIRO, E. M. D. et al. “The challenges of the pandemic and the vaccination against covid-19 in pediatric patients with kidney disease”. Brazilian Journal of Nephrology, vol. 45, n. 2, 2023.
TAREQ, A. M. et al. “Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic”. Human Vaccines & Immunotherapeutics, vol. 17, n. 11, 2021.
TAYLOR, L. “We are being ignored”: Brazil’s researchers blame anti-science government for devastating COVID surge. Nature, vol. 593, n. 7857, 2021.
WANG, J. “Research on the construction of accounting information audit quality control system based on blockchain”.2024.